Stoke Therapeutics (STOK) Non-Current Assets: 2022-2025
Historic Non-Current Assets for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $87.8 million.
- Stoke Therapeutics' Non-Current Assets rose 121.19% to $87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.8 million, marking a year-over-year increase of 121.19%. This contributed to the annual value of $38.8 million for FY2024, which is 198.38% up from last year.
- Stoke Therapeutics' Non-Current Assets amounted to $87.8 million in Q3 2025, which was down 23.32% from $114.5 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Non-Current Assets peaked at $114.5 million during Q2 2025, and registered a low of $9.9 million during Q3 2023.
- Moreover, its 3-year median value for Non-Current Assets was $13.0 million (2023), whereas its average is $34.5 million.
- Per our database at Business Quant, Stoke Therapeutics' Non-Current Assets declined by 24.22% in 2023 and then surged by 964.18% in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Non-Current Assets stood at $12.0 million in 2022, then rose by 8.39% to $13.0 million in 2023, then spiked by 198.38% to $38.8 million in 2024, then surged by 121.19% to $87.8 million in 2025.
- Its last three reported values are $87.8 million in Q3 2025, $114.5 million for Q2 2025, and $31.2 million during Q1 2025.